Expert Advisory Panel on Insulin - Agenda - 2008-10-30

Health Canada
Health Products and Food Branch (HPFB)
Biologic & Genetic Therapies Directorate (BGTD)

Expert Advisory Panel on Insulin

Agenda

Thursday, October 30, 2008, 8:30 a.m. - 4:00 p.m. EDT
200 Tunney's Pasture Driveway, Room 0105

8:40 a.m.
1. Opening Remarks from the BGTD A/Director General, Dr. Elwyn Griffiths and Chair, Dr. John Dupré

Introductions - Sign In Sheet

8:50 a.m.
2. Declarations of Affiliations and Interests for this Meeting and
Ratification of Terms of Reference for Panel
(Dr. Dupré)

9:00 a.m.
3. Review of Today's Agenda
(Dr. Dupré)

9:05 a.m.
4. Health Canada Presentations

4.a Background and Overview
(Ms. Naira Minto-Saeed, BGTD)

4.b Adverse Reaction data available from the Canada Vigilance Database
(Dr. Carole Légaré, MHPD)

10:05 am
4.c Questions by Panel

10:20 a.m.
Coffee Break

10:35 a.m.
5. Perspective of Patients with Diabetes
(Ms. Carol Baker, Insulin Dependent Diabetes Trust International)

11:05 a.m.
5.a Questions by Panel

11:25 a.m.
6. 2008 Canadian Diabetes Association Clinical Practice Guidelines for Insulin Therapy
(Dr. Karen Philp, Canadian Diabetes Association via Teleconference)

11:55 a.m.
6.a Questions by Panel

12:15 p.m.
Lunch

1:00 p.m.
7. Discussion of Questions by the Expert Panel (in camera)
(Dr. Dupré)

3:15 p.m.
8. Wrap Up and Conclusions
(Dr. Dupré)

3:30 p.m.
9. Next Steps
(Dr. Dupré)

3:45 p.m.
10. Adjournment